Literature DB >> 2256020

Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.

N Høiby1, C Koch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2256020      PMCID： PMC462789          DOI： 10.1136/thx.45.11.881

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  35 in total

Review 1.  Antibiotic therapy for bronchopulmonary infections in cystic fibrosis. The American approach.

Authors:  M I Marks
Journal:  Antibiot Chemother (1971)       Date:  1989

Review 2.  The imbalance between granulocyte neutral proteases and antiproteases in bronchial secretions from patients with cystic fibrosis.

Authors:  S Suter
Journal:  Antibiot Chemother (1971)       Date:  1989

Review 3.  Use of antibiotics in cystic fibrosis. The Danish approach.

Authors:  T Jensen; S S Pedersen; N Høiby; C Koch; E W Flensborg
Journal:  Antibiot Chemother (1971)       Date:  1989

4.  Pseudomonas aeruginosa exoenzyme S as a pathogenic determinant in respiratory infections.

Authors:  D E Woods; M To; P A Sokol
Journal:  Antibiot Chemother (1971)       Date:  1989

Review 5.  Immunologic properties of Pseudomonas aeruginosa mucoid exopolysaccharide (alginate).

Authors:  G B Pier
Journal:  Antibiot Chemother (1971)       Date:  1989

Review 6.  Alginate and antibiotics.

Authors:  J R Govan
Journal:  Antibiot Chemother (1971)       Date:  1989

Review 7.  Interactions of Pseudomonas aeruginosa proteases with the cells of the immune system.

Authors:  A Kharazmi
Journal:  Antibiot Chemother (1971)       Date:  1989

Review 8.  Iron-regulated outer membrane proteins and virulence in Pseudomonas aeruginosa.

Authors:  G H Shand; S S Pedersen; K Lam; N Høiby
Journal:  Antibiot Chemother (1971)       Date:  1989

9.  Pneumothorax in pleuropulmonary Kaposi's sarcoma related to acquired immunodeficiency syndrome.

Authors:  C Floris; M L Sulis; M Bernascani; R Turno; A Tedde; E Sulis
Journal:  Am J Med       Date:  1989-07       Impact factor: 4.965

10.  Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.

Authors:  I Eichler; L Joris; Y P Hsu; J Van Wye; R Bram; R Moss
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808
View more
  36 in total

Review 1.  Macrolides in the respiratory tract in cystic fibrosis.

Authors:  Adam Jaffé; Mark Rosenthal
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Viral infections: a role in the lung disease of cystic fibrosis?

Authors:  D J Shale
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

3.  Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.

Authors:  Maria Entezari; Daniel J Weiss; Ravikumar Sitapara; Laurie Whittaker; Matthew J Wargo; JianHua Li; Haichao Wang; Huan Yang; Lokesh Sharma; Binh D Phan; Mohammad Javdan; Sangeeta S Chavan; Edmund J Miller; Kevin J Tracey; Lin L Mantell
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

4.  Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.

Authors:  Dominic Hill; Barbara Rose; Aniko Pajkos; Michael Robinson; Peter Bye; Scott Bell; Mark Elkins; Barbara Thompson; Colin Macleod; Shawn D Aaron; Colin Harbour
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

Review 5.  Microbiology of cystic fibrosis lung infections: themes and issues.

Authors:  J R Govan; J W Nelson
Journal:  J R Soc Med       Date:  1993       Impact factor: 5.344

6.  Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs.

Authors:  J S Elborn; R J Prescott; B H Stack; M C Goodchild; J Bates; C Pantin; N Ali; D J Shale; M Crane
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

7.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

8.  Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments.

Authors:  C Nagant; B Pitts; K Nazmi; M Vandenbranden; J G Bolscher; P S Stewart; J-P Dehaye
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

Review 9.  Fluoroquinolones in the treatment of cystic fibrosis.

Authors:  N Høiby; S S Pedersen; T Jensen; N H Valerius; C Koch
Journal:  Drugs       Date:  1993       Impact factor: 9.546

10.  Neutrophil degranulation by Helicobacter pylori proteins.

Authors:  A Nøorgaard; L P Andersen; H Nielsen
Journal:  Gut       Date:  1995-03       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.